Adempas

Stimulators of the soluble guanylate cyclase ( sGC ) have recently been shown to inhibit transforming growth factor-beta ( TGF-beta...


Riociguat ( Adempas ) is a soluble guanylate cyclase stimulator approved for the treatment of inoperable and persistent / recurrent...


Deficient nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signaling results from endothelial dysfunction and may underlie impaired cardiac relaxation in patients...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of...


Data from the interim analysis of the on-going PATENT-2 trial with Riociguat ( Adempas ), the open-label long-term extension of...